Paolo Tarantino and Davide Massa
May 16, 2025, 05:13
Paolo Tarantino: Davide Massa Presented Interesting Retrospective Analysis at ESMO Breast 2025
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on X:
“Interesting retrospective analysis (n=613) presented by Davide Massa, finding that patients with TNBC and pCR after neoadjuvant treatment harbor a relevant risk of recurrence if the disease was N+ and low-TILs. Caveat: only 20% pts with prior IO.”
More updates on ESMO Breast 2025 on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 7, 2025, 17:41
Jun 7, 2025, 16:47
Jun 7, 2025, 16:40
Jun 7, 2025, 16:30
Jun 7, 2025, 16:07
Jun 7, 2025, 15:49